N,N'-ethylenebis(N-butylmorpholine-4-carboxamide)

Modify Date: 2025-08-23 17:10:51

N,N'-ethylenebis(N-butylmorpholine-4-carboxamide) Structure
N,N'-ethylenebis(N-butylmorpholine-4-carboxamide) structure
Common Name N,N'-ethylenebis(N-butylmorpholine-4-carboxamide)
CAS Number 119-48-2 Molecular Weight 398.54000
Density 1.114g/cm3 Boiling Point 571.3ºC at 760mmHg
Molecular Formula C20H38N4O4 Melting Point N/A
MSDS N/A Flash Point 299.3ºC

 Names

Name N-butyl-N-[2-[butyl(morpholine-4-carbonyl)amino]ethyl]morpholine-4-carboxamide
Synonym More Synonyms

 Chemical & Physical Properties

Density 1.114g/cm3
Boiling Point 571.3ºC at 760mmHg
Molecular Formula C20H38N4O4
Molecular Weight 398.54000
Flash Point 299.3ºC
Exact Mass 398.28900
PSA 65.56000
LogP 1.97080
Vapour Pressure 4.63E-13mmHg at 25°C
Index of Refraction 1.516

 Toxicological Information

CHEMICAL IDENTIFICATION

RTECS NUMBER :
QD9800000
CHEMICAL NAME :
4-Morpholinecarboxamide, N,N'-ethylenebis(N-butyl-
CAS REGISTRY NUMBER :
119-48-2
BEILSTEIN REFERENCE NO. :
0052277
LAST UPDATED :
199612
DATA ITEMS CITED :
8
MOLECULAR FORMULA :
C20-H38-N4-O4
MOLECULAR WEIGHT :
398.62
WISWESSER LINE NOTATION :
T6N DOTJ AVN4&2N4&V- AT6N DOTJ

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
270 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
NIIRDN Drugs in Japan (Ethical Drugs). (Yakugyo Jiho Co., Ltd., Tokyo, Japan) Volume(issue)/page/year: 6,347,1982
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Subcutaneous
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
190 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
NIIRDN Drugs in Japan (Ethical Drugs). (Yakugyo Jiho Co., Ltd., Tokyo, Japan) Volume(issue)/page/year: 6,347,1982
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intravenous
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
24 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
NIIRDN Drugs in Japan (Ethical Drugs). (Yakugyo Jiho Co., Ltd., Tokyo, Japan) Volume(issue)/page/year: 6,347,1982
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intramuscular
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
122 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
NIIRDN Drugs in Japan (Ethical Drugs). (Yakugyo Jiho Co., Ltd., Tokyo, Japan) Volume(issue)/page/year: 6,347,1982
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
380 mg/kg
TOXIC EFFECTS :
Behavioral - convulsions or effect on seizure threshold Behavioral - excitement Lungs, Thorax, or Respiration - other changes
REFERENCE :
AIPTAK Archives Internationales de Pharmacodynamie et de Therapie. (Heymans Institute of Pharmacology, De Pintelaan 185, B-9000 Ghent, Belgium) V.4- 1898- Volume(issue)/page/year: 163,133,1966
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intraperitoneal
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
80 mg/kg
TOXIC EFFECTS :
Behavioral - convulsions or effect on seizure threshold Behavioral - excitement Lungs, Thorax, or Respiration - respiratory stimulation
REFERENCE :
AIPTAK Archives Internationales de Pharmacodynamie et de Therapie. (Heymans Institute of Pharmacology, De Pintelaan 185, B-9000 Ghent, Belgium) V.4- 1898- Volume(issue)/page/year: 163,133,1966
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Subcutaneous
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
104 mg/kg
TOXIC EFFECTS :
Behavioral - convulsions or effect on seizure threshold Behavioral - excitement Lungs, Thorax, or Respiration - respiratory stimulation
REFERENCE :
AIPTAK Archives Internationales de Pharmacodynamie et de Therapie. (Heymans Institute of Pharmacology, De Pintelaan 185, B-9000 Ghent, Belgium) V.4- 1898- Volume(issue)/page/year: 163,133,1966
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intravenous
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
42200 ug/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
NIIRDN Drugs in Japan (Ethical Drugs). (Yakugyo Jiho Co., Ltd., Tokyo, Japan) Volume(issue)/page/year: 6,347,1982

 Safety Information

HS Code 2934999090

 Customs

HS Code 2934999090
Summary 2934999090. other heterocyclic compounds. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0%

 Synonyms

dimorpholamine
Atmurin
EINECS 204-328-7
Prontodin
N,N'-dibutyl-N,N'-ethanediyl-bis-morpholine-4-carboxamide
N,N'-Dibutyl-N,N'-aethandiyl-bis-morpholin-4-carbamid
Theraleptique
Theraptique
1064 TH
Amipan T
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.
Top Suppliers:I want be here


Get all suppliers and price by the below link:

N,N'-ethylenebis(N-butylmorpholine-4-carboxamide) suppliers

N,N'-ethylenebis(N-butylmorpholine-4-carboxamide) price

Related Compounds: More...
[[N,N'-ethylenebis[N-(carboxymethyl)glycinato]](4-)-N,N',O,O',ON,ON']cobaltate(2-)
14931-83-0
N,N'-Ethylenebis(N-butyl-1-piperidinecarboxamide)
7303-46-0
N,N'-ethylenebis[N-(carboxymethyl)glycine], compound with N,N-triethylamine and 2,2',2''-nitrilotris[ethanol]
94108-76-6
N,N'-ethylenebis[N-(carboxymethyl)glycine], compound with 2-amino-2-(hydroxymethyl)propane-1,3-diol (1:2)
93777-65-2
calcium [[N,N'-ethylenebis[N-(carboxymethyl)glycinato]](4-)-N,N',O,O',ON,ON']cuprate(2-)
5497-52-9
dipotassium [[N,N'-ethylenebis[N-(carboxymethyl)glycinato]](4-)-N,N',O,O']palladate(2-)
68025-38-7
dihydrogen [[N,N'-ethylenebis[N-(carboxymethyl)glycinato]](4-)-N,N',O,O',ON,ON']nickelate(2-)
25481-21-4
dipotassium [[N,N'-ethylenebis[N-(carboxymethyl)glycinato]](4-)-N,N',O,O',ON,ON']manganate(2-)
68015-77-0
dipotassium [[N,N'-ethylenebis[N-(carboxymethyl)glycinato]](4-)-N,N',O,O',ON,ON']cobaltate(2-)
14025-10-6
1-[5-(4-Fluorophenyl)-4-methyl-1,1-dioxidoisothiazol-3-yl]piperidin-4-amine hydrochloride
1417567-24-8
1-[5-(4-Isopropylphenyl)-4-methyl-1,1-dioxidoisothiazol-3-yl]piperidin-4-amine hydrochloride
1417566-85-8
1-(4-Methyl-1,1-dioxido-5-phenylisothiazol-3-yl)piperidin-4-amine hydrochloride
1417567-36-2
1-[5-(4-Chlorophenyl)-4-methyl-1,1-dioxidoisothiazol-3-yl]piperidin-4-amine hydrochloride
1417567-73-7
1-[5-(3-Chlorophenyl)-4-methyl-1,1-dioxidoisothiazol-3-yl]piperidin-4-amine hydrochloride
1417568-56-9
3-Methyl-2-piperidin-4-yl-3H-imidazo[4,5-b]pyridinehydrochloride
1417569-77-7
5-(Pyrrolidin-1-ylmethyl)isoxazole-3-carboxylic acid hydrobromide
1417569-78-8
1-[5-Bromo-2-(pyridin-2-ylmethoxy)phenyl]-2,3,4,9-tetrahydro-1H-beta-carboline hydrochloride
1417569-80-2
1-(4-Methoxy-3-{[(5-phenyl-1,3,4-oxadiazol-2-yl)thio]methyl}-phenyl)-2,3,4,9-tetrahydro-1H-beta-carboline hydrochloride
1417568-04-7
2-[(Dimethylamino)methyl]-4-methoxybenzaldehydehydrochloride
1417569-70-0